NUVECTIS PHARMA INC (NVCT)

US67080T1088 - Common Stock

6.61  +1.03 (+18.46%)

After market: 6.36 -0.25 (-3.78%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

MRQ
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
ASSETS
Current Assets
Cash Equivalents
17.17M19.13M19.99M5.74M0.00
Other Current Assets
138.00K59.00K410.00K90.00KN/A
Total Current Assets
17.31M19.18M20.41M5.83M0.00
 
Non-Current Assets
Other Non-Current Assets
N/AN/A0.00820.00KN/A
Total Non-Current Assets
0.000.000.00830.00KN/A
 
TOTAL ASSETS
17.31M19.18M20.41M6.66M0.00
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accrued Expenses
4.05M4.21M2.83M540.00KN/A
Accounts Payable
2.26M2.77M2.91M1.06M10.00K
Other Current Liabilities
N/AN/A450.00K820.00KN/A
Total Current Liabilities
6.32M6.98M6.19M2.42M10.00K
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.000.00
Other Non-Current Liabilities
N/AN/AN/A0.00N/A
Total Non-Current Liabilities
0.000.000.000.000.00
 
TOTAL LIABILITIES
6.32M6.98M6.19M2.42M10.00K
 
SHAREHOLDERS' EQUITY
Retained Earnings
-67.00M-54.24M-31.99M-12.90M-10.00K
Additional Paid In Capital
77.99M66.45M46.20M1.89MN/A
Common Shares
190.00170.000.0015.25M0.00
Other Shareholders' Equity
-190.00-170.000.000.000.00
Shares Outstanding
18.99M17.42M14.64M240.00K240.00K
Tangible Book Value per Share
0.580.700.97-45.88-0.04
Total Shareholders' Equity
10.99M12.20M14.22M4.24M-10.00K
 
TOTAL LIABILITIES AND EQUITY
17.31M19.18M20.41M6.66M0.00
 
Statistics
Current Ratio
2.742.753.302.41N/A
Return On Assets (ROA)
-111.94%-116.03%-93.53%-193.54%N/A
Return On Equity (ROE)
-176.27%-182.44%-134.25%-304.01%N/A

All data in USD , ROIC based on taxRate of 0.21

Charts